Erica Sibley Bahnsen
DOJ’s FY 2022 False Claims Act Recoveries: A Mixed Bag
Health Care and Life Sciences ·
DOJ Announces Enforcement Action Involving “Largest and Most Wide-Ranging” COVID-19 Fraud Detected to Date
Health Care and Life Sciences ·
U.S. Department of Justice Announces Interagency Task Force to Combat COVID-19 Relief Fraud
Administrative and Regulatory ·
Defendant Aventis Pharma Awarded Over $17.2 Million in Attorneys’ Fees in False Claims Act Case
Health Care and Life Sciences ·